Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma. 1990

W P Schilling, and M C Zaher, and D Rampe
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030.

The effects of the inorganic Ca2+ channel blockers Cd2+ and La3+ on dihydropyridine (DHP) binding in highly enriched cardiac sarcolemma preparations has been examined. Cd2+ produced an apparent competitive inhibition of DHP binding with a Ki of 60 microM. DHP binding in the presence of La3+ produced nonlinear Scatchard plots when performed in intact membrane vesicle preparations. Evaluation of DHP binding in saponin-permeabilized vesicles or in the presence of the ionophore A23187 yielded linear Scatchard profiles in the presence of La3+. Under these conditions, La3+ produced a mixed-type inhibition, with effects on both Kd and Bmax. These results suggest that La3+ must have access to the interior of sealed vesicles for expression of full inhibitory activity and that La3+ may produce inhibition of DHP binding by interaction with only one surface of the membrane. In order to evaluate the sidedness of the La3+ interaction, membrane preparations consisting of 74% right side out and 26% leaky vesicles were isolated. In the absence of saponin, La3+ decreased maximum DHP binding in this preparation approximately 25%, with no significant change in Kd. When binding was performed in saponin-permeabilized preparations, however, La3+ produced dramatic decreases in both DHP binding affinity and capacity. These results are consistent with the hypothesis that La3+ produces inhibition of DHP binding by interaction with sites accessible only from the cytoplasmic membrane surface. To obtain additional support for this hypothesis. DHP binding was examined in rat ventricular myocytes grown in culture. La3+ and Cd2+, at concentrations in the extracellular buffer that substantially inhibited K+ depolarization-induced 45Ca2+ influx, had little or no effect on DHP binding.

UI MeSH Term Description Entries
D007811 Lanthanum The prototypical element in the rare earth family of metals. It has the atomic symbol La, atomic number 57, and atomic weight 138.91. Lanthanide ion is used in experimental biology as a calcium antagonist; lanthanum oxide improves the optical properties of glass.
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009568 Nitrendipine A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive. Balminil,Bay e 5009,Bayotensin,Baypresol,Baypress,Gericin,Jutapress,Nidrel,Niprina,Nitre AbZ,Nitre-Puren,Nitregamma,Nitren 1A Pharma,Nitren Lich,Nitren acis,Nitrend KSK,Nitrendepat,Nitrendi Biochemie,Nitrendidoc,Nitrendimerck,Nitrendipin AL,Nitrendipin Apogepha,Nitrendipin Atid,Nitrendipin Basics,Nitrendipin Heumann,Nitrendipin Jenapharm,Nitrendipin Lindo,Nitrendipin Stada,Nitrendipin beta,Nitrendipin-ratiopharm,Nitrendipino Bayvit,Nitrendipino Ratiopharm,Nitrensal,Nitrepress,Tensogradal,Trendinol,Vastensium,nitrendipin von ct,nitrendipin-corax,Nitre Puren,NitrePuren,Nitrendipin ratiopharm,Nitrendipinratiopharm,nitrendipin corax,nitrendipincorax
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D011813 Quinuclidinyl Benzilate A high-affinity muscarinic antagonist commonly used as a tool in animal and tissue studies. Benzilate, Quinuclidinyl
D002104 Cadmium An element with atomic symbol Cd, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004095 Dihydropyridines Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.

Related Publications

W P Schilling, and M C Zaher, and D Rampe
January 1991, Advances in experimental medicine and biology,
W P Schilling, and M C Zaher, and D Rampe
December 1987, Biochemical pharmacology,
W P Schilling, and M C Zaher, and D Rampe
January 1975, Recent advances in studies on cardiac structure and metabolism,
W P Schilling, and M C Zaher, and D Rampe
January 2008, Prikladnaia biokhimiia i mikrobiologiia,
W P Schilling, and M C Zaher, and D Rampe
July 1985, The Journal of biological chemistry,
W P Schilling, and M C Zaher, and D Rampe
December 1988, The Journal of pharmacology and experimental therapeutics,
W P Schilling, and M C Zaher, and D Rampe
May 2000, Acta anaesthesiologica Scandinavica,
W P Schilling, and M C Zaher, and D Rampe
December 1991, Circulation,
W P Schilling, and M C Zaher, and D Rampe
January 1991, Anesthesiology,
W P Schilling, and M C Zaher, and D Rampe
August 1988, Biochimica et biophysica acta,
Copied contents to your clipboard!